David Zipes, MD, FAAP, Pediatric Hospitalist, Director of Pediatric Hospitalist Program Peyton Manning Children’s Hospital Indianapolis, Society of Hospital Medicine Fellow in Hospital Medicine, discusses his own business…
Marsha Guess, MD, Assistant Professor of Obstetrics, Gynecology and Reproductive Medicine at Yale University, discusses overactive bladder treatment with newer drugs such as trospium chloride, and reminds physicians…
Marsha Guess, MD, Assistant Professor of Obstetrics, Gynecology and Reproductive Medicine at Yale University, discusses altered sexual function in women and a Yale study that is looking at…
NEW YORK (Reuters Health) – Because cholinesterase inhibitors induce can bradycardia, particularly at higher doses, physicians are being urged to closely monitor patients treated with these medications, especially…
NEW YORK (Reuters Health) – Use of erythropoiesis-stimulating agents in US cancer patients undergoing chemotherapy has increased 10-fold since their introduction, yet there’s been no associated decline in…
NEW YORK (Reuters Health) – Lipid assessment of vascular disease risk can be simplified by measuring either cholesterol levels or apolipoproteins, without fasting and without looking at triglyceride…
NEW YORK (Reuters Health) – Adding angioplasty to medical therapy does not improve the outcomes of patients with renal-artery stenosis and carries substantial risks, according to a report…
NEW YORK (Reuters Health) – Keeping hypoxic patients with acute respiratory distress syndrome (ARDS) in the prone position does not reduce mortality, although it might provide a slight…
NEW YORK (Reuters Health) – Long-term ambrisentan therapy safely improves exercise capacity in patients with pulmonary arterial hypertension (PAH), according to results of an extension protocol that followed…
NEW YORK (Reuters Health) – In kidney transplant recipients, bringing hemoglobin levels above 125 g/L with erythropoietin may increase mortality, according to a report in the November 6th…